Periprocedural adverse events in cell therapy trials in myocardial infarction and cardiomyopathy: a systematic review

scientific article published on 28 September 2012

Periprocedural adverse events in cell therapy trials in myocardial infarction and cardiomyopathy: a systematic review is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00392-012-0508-3
P698PubMed publication ID23052331

P2093author name stringErnst R Schwarz
Aldo Maggioni
Alejandro Barbagelata
Anita Phan
Rajesh Ramineni
Paulino A Alvarez
Carlos Boissonnet
Clay Barbin
Phil Myatt
P2860cites workAutologous mononuclear bone marrow cells during reparative regeneratrion after acute myocardial infarctionQ83941697
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial InfarctionQ22250889
2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaborationQ22306346
Adverse effects of biologics: a network meta-analysis and Cochrane overviewQ24234197
The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarctionQ28248284
The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart studyQ28286170
Inducible apoptosis as a safety switch for adoptive cell therapyQ29617710
Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.Q30444845
Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarctionQ30824170
Transcoronary transplantation of progenitor cells after myocardial infarctionQ30824315
Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trialQ31033745
Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trialQ33263365
Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysisQ33285990
Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic reviewQ33340205
Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.Q33374961
Intracoronary administration of stem cells in patients with acute myocardial infarction - angiographic follow-up.Q33466900
Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trialQ33505911
Results of intracoronary stem cell therapy after acute myocardial infarctionQ33538384
Completeness of safety reporting in randomized trials: an evaluation of 7 medical areasQ33937374
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.Q34010010
Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repairQ34103630
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trialQ34332467
Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working GroupQ34346205
Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step .Q34550669
Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart diseaseQ35070251
Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI).Q35772741
Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized studyQ36322384
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarctionQ36634299
Cardiovascular events and re-stenosis following administration of G-CSF in acute myocardial infarction: systematic review and meta-analysis.Q36924655
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collQ37028681
Stem cell therapy is proarrhythmicQ37336616
Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005Q37402737
Stem cells are not proarrhythmic: letting the genie out of the bottle.Q37435260
Stem cell therapy for heart failure: are arrhythmias a real safety concern?Q37496407
Cell therapy for the treatment of coronary heart disease: a critical appraisalQ37696967
Cardiac cell therapy: lessons from clinical trialsQ37769840
Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious careQ37976396
Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactionsQ38417798
Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathyQ39347068
Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clQ40525372
Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery.Q44229341
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunctionQ44392643
Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failureQ44411377
Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression.Q45022812
Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunctionQ45198815
Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs.Q45958753
Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safetyQ46700940
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart FailuQ47849023
Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phaseQ47860320
Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarctionQ48831721
Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imagingQ48946348
Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function.Q50774320
Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction.Q50776586
Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarctionQ51168550
Stem cell therapy for myocardial repair: is it arrhythmogenic?Q51783314
Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial.Q51797011
Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy.Q53149136
The international pandemic of chronic cardiovascular disease.Q53240008
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trialQ56610959
Lifetime Risk for Developing Congestive Heart FailureQ57073232
Long-Term Trends in the Incidence of and Survival with Heart FailureQ57073236
Trends in Heart Failure Incidence and Survival in a Community-Based PopulationQ57540294
Lost in translationQ59057872
Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by IntQ61942700
Team management of patients with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart AssociationQ73162822
Reporting of safety data from randomised trialsQ77664569
Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in MyQ79615200
The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI)Q79843933
Lack of additional benefit of intracoronary transplantation of autologous peripheral blood stem cell in patients with acute myocardial infarctionQ80033976
Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarctionQ80246358
[Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function]Q80374410
Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized studyQ80485648
Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarctionQ80673912
Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspectsQ81191191
Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardiumQ81845589
P433issue1
P304page(s)1-10
P577publication date2012-09-28
P1433published inClinical Research in CardiologyQ2665050
P1476titlePeriprocedural adverse events in cell therapy trials in myocardial infarction and cardiomyopathy: a systematic review
P478volume102

Reverse relations

Q38267653Investigating the role of acute mental stress on endothelial dysfunction: a systematic review and meta-analysiscites workP2860

Search more.